Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis
- PMID: 36001098
- DOI: 10.1007/s00192-022-05326-y
Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis
Abstract
Introduction and hypothesis: Pelvic floor dysfunction (PFD) and female sexual dysfunction (FSD) are symptoms that affect the quality of life of patients with cervical cancer (CC) after treatment. Our purpose was to estimate the prevalence of urinary incontinence (UI) and fecal incontinence (FI) associated with PFD and prevalence of FSD in CC patients.
Methods: We searched PubMed, Embase, and the Cochrane Library from database inception to 31 January 2021 and selected articles assessing UI, FI and FSD in women with CC. Observational studies were included if they investigated UI, FI, and FSD.
Results: We included 14 of the 1,233 studies: 7 investigated FSD, 9 UI, and 3 FI. The results were highly heterogeneous because of the different populations and treatment methods. The prevalence of FSD, UI, and FI in CC patients after treatment was 45.0% (95% CI, 21.8-68.3%), 34.1% (95% CI, 25.5-42.7%), and 11.1% (95% CI, 4.8-17.3%). The results showed that different countries were the source of high heterogeneity of UI and FI (P<0.001).
Conclusions: In this meta-analysis, the prevalence of PFD and FSD was high. These results are important for drawing attention to PFD and its early prevention and rehabilitation.
Keywords: Cervical cancer; Female sexual dysfunction; Meta-analysis; Pelvic floor disorders; Prevalence.
© 2022. The International Urogynecological Association.
Similar articles
-
Natural history of pelvic floor disorders before and after hysterectomy for gynaecological cancer.BJOG. 2024 Oct;131(11):1545-1554. doi: 10.1111/1471-0528.17870. Epub 2024 May 29. BJOG. 2024. PMID: 38812271
-
Pelvic floor disorders and sexuality in women with ovarian cancer: A systematic review.Gynecol Oncol. 2021 Apr;161(1):264-274. doi: 10.1016/j.ygyno.2021.01.026. Epub 2021 Jan 27. Gynecol Oncol. 2021. PMID: 33516528
-
Association between pelvic floor dysfunction, and clinical and ultrasonographic evaluation in primiparous women: a cross-sectional study.Arch Gynecol Obstet. 2018 Aug;298(2):345-352. doi: 10.1007/s00404-018-4811-8. Epub 2018 Jun 14. Arch Gynecol Obstet. 2018. PMID: 29948172
-
Prevalence of depression and anxiety in women with pelvic floor dysfunctions: A systematic review and meta-analysis.Int J Gynaecol Obstet. 2024 Nov;167(2):507-528. doi: 10.1002/ijgo.15719. Epub 2024 Jun 11. Int J Gynaecol Obstet. 2024. PMID: 38859723 Review.
-
Pelvic floor disorders in women with gynecologic malignancies: a systematic review.Int Urogynecol J. 2018 Apr;29(4):459-476. doi: 10.1007/s00192-017-3467-4. Epub 2017 Sep 19. Int Urogynecol J. 2018. PMID: 28929201 Free PMC article. Review.
Cited by
-
High uterosacral ligament suspension in radical hysterectomy: a step-by-step procedure to prevent pelvic organ prolapse.Int Urogynecol J. 2023 Nov;34(11):2839-2842. doi: 10.1007/s00192-023-05592-4. Epub 2023 Jul 7. Int Urogynecol J. 2023. PMID: 37417994
-
Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients.Transl Cancer Res. 2023 May 31;12(5):1307-1314. doi: 10.21037/tcr-23-385. Epub 2023 Apr 24. Transl Cancer Res. 2023. PMID: 37304532 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492 . - DOI
-
- Small W Jr, Bacon MA, Bajaj A, Chuang LT, Fisher BJ, Harkenrider MM, et al. Cervical cancer: a global health crisis. Cancer. 2017;123(13):2404–12. https://doi.org/10.1002/cncr.30667 . - DOI
-
- Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203. https://doi.org/10.1016/s2214-109x(19)30482-6 . - DOI
-
- Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. https://doi.org/10.1016/s0140-6736(17)33326-3 . - DOI
-
- Vu M, Yu J, Awolude OA, Chuang L. Cervical cancer worldwide. Curr Probl Cancer. 2018;42(5):457–65. https://doi.org/10.1016/j.currproblcancer.2018.06.003 . - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical